LIMK1 and cervical carcinoma: Comparison of scratch spacing between the Saracatinib-NC group and Saracatinib-LIMK1 overexpression group of cervical cancer cells reveals that Saracatinib reverses the effect of LIMK1 on the migration of cervical cancer cells.